VPR AND HIV1 NUCLEAR TRANSLOCATION

Information

  • Research Project
  • 6169839
  • ApplicationId
    6169839
  • Core Project Number
    R01AI033776
  • Full Project Number
    5R01AI033776-08
  • Serial Number
    33776
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/1/1993 - 31 years ago
  • Project End Date
    6/30/2001 - 23 years ago
  • Program Officer Name
    PLAEGER, SUSAN F.
  • Budget Start Date
    7/1/2000 - 24 years ago
  • Budget End Date
    6/30/2001 - 23 years ago
  • Fiscal Year
    2000
  • Support Year
    8
  • Suffix
  • Award Notice Date
    7/27/2000 - 23 years ago

VPR AND HIV1 NUCLEAR TRANSLOCATION

DESCRIPTION: Following completion of reverse transcription, the HIV cDNA becomes integrated into a host chromosome. For this to take place, the HIV "preintegration complex" (PIC) must be transported to the location of the host chromosomes. For the case of multiplication of non-dividing cells, a characteristic of HIV, the PIC must pass through the host nuclear membrane to achieve integration. Dr. Bukrinsky has made a number of contribution in studies of subcellular sorting of PICs, and proposed to continue his studies in this renewal. Work will focus on the viral-encoded protein vpr. In a nuclear localization sequence (NLS) in MA protein and the vpr protein contribute karyophillic signals to the PIC. Extensive work by others has elucidated several of the proteins involved in nuclear localization, including karyopherins, proteins that function in part by binding NLS sequences. In this renewal, Dr. Bukrinsky proposes to: 1) characterize the Vpr-karyopherin alpha interaction; 2) investigate the effects of Vpr on interactions of karyopherins with MA and other NLS-containing proteins; 3) demonstrate the effect of Vpr on the process of nuclear import; and 4) determine the role of Vpr and Vpx in HIV-2/SIV nuclear import. The investigator has published extensively in this area and is familiar with many of the methods necessary to carry out the study.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R01
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    220027
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
    NIAID:220027\
  • Funding Mechanism
  • Study Section
    ARRC
  • Study Section Name
    AIDS and Related Research Study Section 3
  • Organization Name
    PICOWER INSTITUTE FOR MEDICAL RESEARCH
  • Organization Department
  • Organization DUNS
  • Organization City
    MANHASSET
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    11030
  • Organization District
    UNITED STATES